BDBM644629 Preparation of 7,7-dimethyl-11-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-17λ6-thia-2,8,10,16,22-pentaazatetracyclo[16.3.1.04,8.09,14]docosa-1(22),9,11,13,18,20-hexaene-15,17,17-trione ::US11866450, Compound 41

SMILES CC1(C)CCC2CNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(nc3N12)-n1ccc(OCCC2(CC2)C(F)(F)F)n1

InChI Key InChIKey=AIQAEROFGSMFMX-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 644629   

TargetCystic fibrosis transmembrane conductance regulator(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM644629(US11866450, Compound 41 | Preparation of 7,7-dimet...)
Affinity DataEC50: >3.00E+3nMAssay Description:Bath 1 Buffer consisted of 1 mM MgCl2, 160 mM NaCl, 4.5 mM KCl, 10 mM HEPES, 10 mM Glucose, 2 mM CaCl2).Chloride Free Buffer consisted of 1 mM Magnes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2024
Entry Details
Go to US Patent